(Reuters) - Merck (NS: PROR) said on Monday its drug, Winrevair, helped significantly reduce the risk of death in patients ...

Intelligent Bio Solutions unveils strong initial results for its PK study, which is important for FDA submission of its Intelligent Fingerprinting Drug Screening System.

Moderna, Inc.'s stock plummets as challenges mount, including vaccine skepticism, competitive pressures, and the RFK ...

The value of charities’ investable assets has stabilised and, in some cases, improved over the last 12 months, research from ...

One of the strategies financial experts recommend is dollar-cost averaging, where investors invest on an ongoing basis, ...

Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to Buy while trimming the target price to $58 from $82.

Nvidia helped pull U.S. stock indexes higher after they stumbled in the morning on worries about escalations in the ...

After Seelos Therapeutics’ amyotrophic lateral sclerosis (ALS) candidate failed a phase 2/3 study, the biotech has filed for ...

The Information reports that Blackwell chips are overheating at data centers. Nvidia reports Q3 earnings on Wednesday with ...

Ken Griffin started the Citadel hedge fund in 1990. In the third quarter, Griffin and Citadel more than tripled its stake in ...

Latest on LIXT: Exclusive BAC Article: LIXTE Biotechnology; Q1 Of 2025 LB-100 ASTS Data, Two Small Studies Funded By Big Pharma And Catalysts ...

A housing study is recommending Oswego diversify its housing market to attract more first time home buyers as well as ...